Areas hard-hit by the COVID-19 pandemic may be experiencing a decreased supply of dialysate solution bags, which are used in continuous renal replacement therapy. A low or threatened supply of dialysate may compromise care for patients with kidney disease who rely on dialysis.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Nearly 30 years ago, Cleveland Clinic began producing its own solution in-house using industry-standard technology. Today, Sevag Demirjian, MD, Director of Critical Care Nephrology, and his team share step-by-step instructions for the in-house production of ultra-pure continuous hemodialysis fluid in the video featured below. This video was created to offer support and instruction to other healthcare centers that may be interested in producing their own dialysate solution:
By using the information in this video and/or any other materials made available by Cleveland Clinic related to the dialysate solution, you agree to comply with and be bound by the terms of the Permissive Use Agreement, a copy of which is available here.
